|
During the forum, BPBC also held a breakfast meeting, reception dinner, cocktail reception, and other activities to enrich the forum in forms and to establish a multi-level flatform for comprehensive communication with leading multinational companies, international industrial organistations, to help ABO seek potential cooperative opportunities. BPBC launched fruitful talks with principals from Novartis, Pfizer, Roche, GlaxoSmithKline, Johnson & Johnson, AstraZeneca, Novo Nordisk, PharmaNet, SAPA , Chief Biotechnology Industry Organization(BIO), DAC consulting company; Most guests highly praised that, the internationalization of the HIF, the speech level, the organization, the form and content, as well as the a platform provided for exchanging, all is in line with international standards of excellence as an international conference. They said the 12 HIF was the most successful session in recent years, and they would help promote the healthy development of the ABO in the future.
|